Rothman KJ, Suissa S. Exclusion of immortal person-time. Pharmacoepidemiol Drug Saf. 2008 Oct 1;17(10):1036.
Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Arana A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Pharmacoepidemiol Drug Saf. 2008 Oct 1;17(10):1037. doi: 10.1002/pds.1636
Danese MD, Belozeroff V, Smirnakis K, Rothman KJ. Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol. 2008 Sep 1;3(5):1423-9.
Solomon DH, Glynn RJ, Rothman KJ, Schneeweiss S, Setoguchi S, Mogun H, Avorn J, Sturmer T. Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. Arthritis Care Res (Hoboken). 2008 Aug 15;59(8):1097-104.
Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes. 2008 Aug 1;32 Suppl 3:S56-9.
Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Rothman KJ, Fischer M, Mehta J, Winkelmayer WC. The effect of altitude on dosing and response to erythropoietin in ESRD. J Am Soc Nephrol. 2008 Jul 1;19(7):1389-95.
Bradbury BD, Wang O, Critchlow CW, Rothman KJ, Heagerty P, Keen M, Acquavella JF. Relative mortality and epoetin alfa dose in hemodialysis patients - Reply. Am J Kidney Dis. 2008 May 1;51(5):865-6.
Pedersen L, Norgaard M, Rothman KJ, Sorensen HT. Loratadine during pregnancy and hypospadias. Epidemiology. 2008 Mar 1;19(2):359-60.
Stuermer T, Rothman KJ, Avorn J. Pharmacoepidemiology and "in silico" drug evaluation: is there common ground? J Clin Epidemiol. 2008 Mar 1;61(3):205-6.
Hutchison GB, Rothman KJ, Cole P, Mack T, Weiss NS, Monson RR. Remembrance. Brian MacMahon, 1923-2007. Epidemiology. 2008 Mar;19(2):357.
Hutchison GB, Rothman KJ, Cole P, Mach T, Weiss NS, Monson RR. Brian MacMahon, 1923-2007. Epidemiology. 2008 Mar 1;19(2):357.
Rothman KJ, Greenland S, Lash TL. Case-control studies. In: Everitt B, Melnick E, editors. Encyclopedia of quantitative risk analysis and assessment. New York: United States. Wiley; 2008.
Bradbury BD, Wang O, Critchlow CW, Rothman KJ, Heagerty P, Keen M, Acquavella JF. Exploring relative mortality and epoetin alfa dose among hemodialysis patients. Am J Kidney Dis. 2008 Jan 1;51(1):62-70.
Lanes SF, Delzell E, Dreyer NA, Rothman KJ. Analgesics and kidney disease. Int J Epidemiol. 1986 Dec;15(4):454-5. doi: 10.1093/ije/15.4.454
Rothman KJ. Significance questing. Ann Intern Med. 1986 Jan 1;105(3):445-7. doi: 10.7326/0003-4819-105-3-445
Rothman KJ. Interpretation of epidemiologic studies on smokeless tobacco and cancer. In: Health implications of smokeless tobacco. Bethesda: MD. NIH Consensus Development Conference; 1986.
Jick H, Walker AM, Rothman KJ. Vaginal spermicides and congenital disorders - the validity of a study-reply. JAMA. 1986 Jan 1;256(22):3095-6.